Stock listing
ALINT Stock Price, News, Filings & Events — Integragen Sa
Selected listing: ALINT · EURONEXT · EUR · FR
This page tracks Integragen Sa's ALINT:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALINT:EURONEXT. ALINT:EURONEXT is the stock-level entry point for investors researching Integragen Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Integragen Sa is a public company listed on the Euronext Paris under the ticker ALINT. Based in France, the company has a market capitalization of approximately €1.17 million. Integragen focuses on providing genomic analysis and bioinformatics services to advance research and healthcare solutions.

- Ticker
- ALINT:EURONEXT
- Asset type
- Stock
- Market cap
- $1.4M
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- EURONEXT
- Currency
- EUR
Integragen Sa ALINT:EURONEXT stock context
This page tracks Integragen Sa's ALINT:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALINT:EURONEXT. ALINT:EURONEXT is the stock-level entry point for investors researching Integragen Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Integragen Sa is a public company listed on the Euronext Paris under the ticker ALINT. Based in France, the company has a market capitalization of approximately €1.17 million. Integragen focuses on providing genomic analysis and bioinformatics services to advance research and healthcare solutions.
Latest news from Integragen Sa
IntegraGen: Sales of €2.5 Million in the First Half of 2025 and Cash Position of €2.1 Million
July 2, 2025
IntegraGen: 2024 Annual Results
April 29, 2025
IntegraGen: 2024 Revenues of €8.5m, Down 27% Compared With 2023 (+5% Excluding SeqOIA), and Cash Position of €1.9m
January 15, 2025
IntegraGen: 2024 Half-Year Results - Sales up 6% on a Like-for-Like Basis (Excluding SeqOIA) and Profitability Maintained
October 17, 2024
IntegraGen : reports €4.5m in revenues for H1 2024 representing 6% increase compared to H1 2023 and a cash position of €2.8m
July 24, 2024
Research Integragen Sa
Integragen Sa investor report
Review AI stock analysis and investor report context for ALINT:EURONEXT.
Integragen Sa company profile
View the public company page for Integragen Sa on 6ix.
Integragen Sa news
Read company news and market updates connected to Integragen Sa.
Integragen Sa investor events
Find investor webinars, events, and replay context for Integragen Sa.
Alternate listings
A1J1JV:LSX
DE · EUR
Alternate listing for Integragen Sa; the primary context on this page is ALINT:EURONEXT.
A1J1JV:LS
DE · EUR
Alternate listing for Integragen Sa; the primary context on this page is ALINT:EURONEXT.
ALINTP:TURQUOISE
GB · EUR
Alternate listing for Integragen Sa; the primary context on this page is ALINT:EURONEXT.
7N8:SWB
DE · EUR
Alternate listing for Integragen Sa; the primary context on this page is ALINT:EURONEXT.